Latest News by Industry
Taysha Gene Therapies, Inc. [TSHA] has reported fiscal Q1 loss of $17.60 million.
On a per-share basis, the DE based company said its diluted earnings are $0.28.
The Biological Products, Except Diagnostic Substances firm posted revenue of $4.70 million in this period.